Results 251 to 260 of about 21,384 (315)

A Ferritin-Based Eg95 Nanoparticle Vaccine Adjuvanted with pCpG Eliciting Robust Immune Responses Against Cystic Echinococcosis in Mice Model. [PDF]

Int J Nanomedicine
Gao X, Zhu X, Liu X, Zhou C, Shang Y, Wu T, Jia H, Zhang Z, Li Y, Xin T.   +9 more
europepmc   +1 more source

Treatment of peri‐implantitis with diode laser or mucosal flap surgery: A clinical randomized controlled trial

Journal of Periodontology, EarlyView.
Abstract Background Peri‐implantitis poses a major challenge as contemporary nonsurgical treatments show dissatisfactory results and mucosal flap surgery is often needed. Diode lasers can remove granulation tissue and submucosal bacteria, and if it achieves similar clinical results, then it could be used as a less invasive first approach.
Sebastian Malmqvist, Talat Qadri, Ronaldo Lira‐Junior, Elisabeth A. Boström, Anders Gustafsson, Georgios N. Belibasakis, Angelika Silbereisen, Gunnar Johannsen, Annsofi Johannsen   +8 more
wiley   +1 more source

PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies. [PDF]

Hum Vaccin Immunother
Hickey JM, Sharma N, Fairlamb M, Doering J, Adewunmi Y, Prieto K, Costa G, Wizel B, Levashina EA, Mantis NJ, Julien JP, Joshi SB, Volkin DB.   +12 more
europepmc   +1 more source

Machine learning‐assisted prediction of clinical responses to periodontal treatment

Journal of Periodontology, EarlyView.
Abstract Background Periodontitis is among the most prevalent chronic inflammatory conditions globally, and is associated with bone resorption, tooth loss, and systemic complications. While its treatment is largely standardized, individual outcomes vary, with some patients experiencing further disease progression despite adherence. Methods We developed
Balazs Feher, Eduardo H. de Souza Oliveira, Poliana Mendes Duarte, Andreas A. Werdich, William V. Giannobile, Magda Feres   +5 more
wiley   +1 more source

Oncolytic VSV-IL-2 has enhanced anticancer vaccination adjuvant abilities. [PDF]

J Immunother Cancer
Mullins-Dansereau V, Myre ML, Bardoul A, Geoffroy K, Rallo Pita MJ, Béland D, Desaulniers KL, Roy DG, Bourgeois-Daigneault MC.   +8 more
europepmc   +1 more source

AO/AAP consensus on prevention and management of peri‐implant diseases and conditions: Summary report

Journal of Periodontology, EarlyView.
Abstract Background The exponential increase in dental implant use has led to a parallel rise in peri‐implant diseases (PID), adversely affecting implant therapy success and patient quality of life. Efforts have been made by the dental community to understand systemic, behavioral, and site‐level risk factors involved in the etiologies and pathogenesis ...
Hom‐Lay Wang, Gustavo Avila‐Ortiz, Alberto Monje, Purnima Kumar, Javier Calatrava, Tara Aghaloo, Shayan Barootchi, Joseph P. Fiorellini, Maria Elisa Galarraga‐Vinueza, Joseph Kan, Guo‐Hao Lin, Andrea Ravida, Muhammad H. A. Saleh, Lorenzo Tavelli, AO/AAP Consensus Participants, Paul S. Rosen   +15 more
wiley   +1 more source

Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines. [PDF]

Hum Vaccin Immunother
Paul S, Kaya M, Johnsson O, Grauers Wiktorin H, Törnell A, Arabpour M, Hellstrand K, Martner A.   +7 more
europepmc   +1 more source

Prehabilitation of Patients With Oesophageal Malignancy Undergoing Peri‐Operative Treatment (Pre‐EMPT): Outcomes From a Prospective Controlled Trial

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background The Pre‐EMPT study aimed to determine if structured exercise could reduce length of stay, post‐operative complications and improve fitness and health‐related quality of life (HQRL) in patients undergoing neoadjuvant chemotherapy (NAC) and oesophagectomy.
R. Bott, J. Zylstra, W. Knight, G. P. Whyte, A. M. Lane, C. Moss, M. Browning, J. Lagergren, M. Van Hemelrijck, A. R. Davies, the Pre‐EMPT study group including the following co‐authors, J. Gossage, M. Kelly, C. Baker, J. Taylor, O. Rusu, O. Evans, G. Tham, T. Dixon, G. Hallward, C. Taylor, N. Maisey, S. Ngan, A. Lumsden, K. Owczarczyk, A. Qureshi, N. Griffin, A. Jacques, V. Goh, M. Green, H. Deere, F. Chang, U. Mahadeva, B. Gill‐Barman, M. Ong, S. George, J. Dunn, S. Zeki, J. Waters, M. Cominos, T. Sevitt, M. Hill, A. Santa Ollala, K. Beckmann, L. Gervais‐Andre, J. Pate   +45 more
wiley   +1 more source

Glycemic control and vaccine response: the role of mucosal immunity after vaccination in diabetic patients. [PDF]

Front Immunol
Mojaddidi MA, Aboonq M, Alqahtani SA.
europepmc   +1 more source

COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a common non‐scarring alopecia. Data continue to emerge on associations with autoimmune and other conditions. Janus kinase inhibitors (JAKi) are increasingly used to treat AA. Objectives The aim was to assess variation in laboratory testing in patients with AA among hair experts internationally and to compare
Cathal O'Connor, Aoife Boyle, Leila Asfour, Bevin Bhoyrul, Laita Bokhari, George Cotsarelis, Chantal Cotter, Brittany Craiglow, Lara Cutlar, Rachita Dhurat, Ncoza Dlova, Isabella Doche, Jeff Donovan, Aaron M. Drucker, Samantha Eisman, Daniel Fernandes Melo, Matthew J. Harries, Maria Hordinsky, Ahmed Kazmi, Brett King, Antonios Kolios, Nekma Meah, Paradi Mirmirani, Arash Mostaghimi, Manabu Ohyama, Yuliya Ovcharenko, Rodrigo Pirmez, Bianca Maria Piraccini, Lidia Rudnicka, David Saceda‐Corralo, Jerry Shapiro, Cathryn Sibbald, Rod Sinclair, Blake R. C. Smith, Michela Starace, Sergio Vaño‐Galván, Wei Liang Koh, Katherine York, Ian McDonald, Dmitri Wall   +39 more
wiley   +1 more source